Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Batchelor

Showing results (281-290 of 321) with videos related to

Pageof 33
Sort By:
NPJ Precision Oncology|June 7, 2018
Clinical and radiographic response following targeting of BCAN-NTRK1 fusion in glioneuronal tumorChristopher Alvarez-Breckenridge, Julie J Miller, Naema Nayyar, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2016
Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survivalJonas Kloepper, Lars Riedemann, Zohreh Amoozgar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2015
A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma PatientsEudocia Q Lee, Thomas J Kaley, Dan G Duda, et al.
Nature Communications|March 29, 2024
Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutantsTikvah K Hayes, Elisa Aquilanti, Nicole S Persky, et al.
Blood|February 15, 2022
Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trialMatthew J Frigault, Jorg Dietrich, Kathleen Gallagher, et al.
Nature Communications|April 16, 2024
Author Correction: Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutantsTikvah K Hayes, Elisa Aquilanti, Nicole S Persky, et al.
Neuro-Oncology|December 15, 2025
Prognostic Significance of MGMT Promoter Methylation Status in IDH-mutant GliomaGilbert Youssef, Elisa Aquilanti, Julie J Miller, et al.
Neurosurgery|June 20, 2019
Letter: When Less is More: Dexamethasone Dosing for Brain TumorsMary Jane Lim-Fat, Wenya Linda Bi, Janet Lo, et al.
British Journal of Cancer|February 13, 2001
Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabineK A Jaeckle, S Phuphanich, M J Bent, et al.
Neuro-Oncology|June 14, 2019
Automatic assessment of glioma burden: a deep learning algorithm for fully automated volumetric and bidimensional measurementKen Chang, Andrew L Beers, Harrison X Bai, et al.
Pageof 33

Showing results (281-290 of 321) with videos related to

Sort By:
Pageof 33
NPJ Precision Oncology|June 7, 2018
Clinical and radiographic response following targeting of BCAN-NTRK1 fusion in glioneuronal tumorChristopher Alvarez-Breckenridge, Julie J Miller, Naema Nayyar, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2016
Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survivalJonas Kloepper, Lars Riedemann, Zohreh Amoozgar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2015
A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma PatientsEudocia Q Lee, Thomas J Kaley, Dan G Duda, et al.
Nature Communications|March 29, 2024
Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutantsTikvah K Hayes, Elisa Aquilanti, Nicole S Persky, et al.
Blood|February 15, 2022
Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trialMatthew J Frigault, Jorg Dietrich, Kathleen Gallagher, et al.
Nature Communications|April 16, 2024
Author Correction: Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutantsTikvah K Hayes, Elisa Aquilanti, Nicole S Persky, et al.
Neuro-Oncology|December 15, 2025
Prognostic Significance of MGMT Promoter Methylation Status in IDH-mutant GliomaGilbert Youssef, Elisa Aquilanti, Julie J Miller, et al.
Neurosurgery|June 20, 2019
Letter: When Less is More: Dexamethasone Dosing for Brain TumorsMary Jane Lim-Fat, Wenya Linda Bi, Janet Lo, et al.
British Journal of Cancer|February 13, 2001
Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabineK A Jaeckle, S Phuphanich, M J Bent, et al.
Neuro-Oncology|June 14, 2019
Automatic assessment of glioma burden: a deep learning algorithm for fully automated volumetric and bidimensional measurementKen Chang, Andrew L Beers, Harrison X Bai, et al.
Pageof 33